{"hands_on_practices": [{"introduction": "The foundation of many immunological assays is the determination of a 'titer,' which quantifies the concentration of an antibody or antigen. In a Hemagglutination Inhibition (HAI) assay, this involves finding the highest serum dilution that can still prevent virus-mediated agglutination of red blood cells. This practice problem will challenge you to apply the precise definition of an HAI titer to a set of experimental observations, a fundamental skill for interpreting results in virology and immunology. [@problem_id:5088316]", "problem": "A clinical virology laboratory is performing a hemagglutination inhibition (HAI) assay to quantify antibodies against an influenza virus in a human serum sample. The assay uses a standard microtiter setup with two-fold serial serum dilutions prepared in phosphate-buffered saline, equal-volume mixing with virus and red blood cells (RBCs), and readout by visual scoring of RBC buttons versus lattice formation.\n\nAssay conditions are as follows:\n- Influenza virions are pre-titrated by hemagglutination (HA) against standardized RBCs to determine the hemagglutinating unit (HAU). By definition, $1$ HAU is the smallest amount of virus that produces complete hemagglutination under the assay conditions. The laboratory uses an input of $4$ HAU per well for the HAI assay.\n- Serum is serially diluted two-fold from $1{:}10$ through $1{:}1280$ and incubated with the virus, followed by addition of $0.5\\%$ RBCs (v/v).\n- The readout is binary for complete inhibition (compact RBC button, no lattice) versus no inhibition (uniform lattice), with an intermediate category of partial inhibition (incomplete lattice or teardrop), which does not meet the criterion for complete inhibition.\n\nIn this experiment, the observed results for the sample are:\n- Complete inhibition at $1{:}80$ and $1{:}160$.\n- Partial inhibition at $1{:}320$.\n- No inhibition at $1{:}640$ and higher dilutions.\n\nUsing only fundamental definitions of hemagglutination, hemagglutination inhibition, and the endpoint definition used in HAI, determine the HAI titer to be reported for this sample. Express the HAI titer as the reciprocal of the highest serum dilution that meets the complete inhibition criterion. Report the final value as a single unitless integer (no units) and no rounding is required beyond the exact integer value.", "solution": "The problem requires the determination of the Hemagglutination Inhibition (HAI) titer from a set of experimental results. A systematic validation of the problem statement is the necessary first step.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- **Assay Type**: Hemagglutination inhibition (HAI) assay for influenza virus antibodies.\n- **Assay Components**: Human serum, influenza virions, red blood cells (RBCs), phosphate-buffered saline (PBS).\n- **Virus Standardization**: $1$ hemagglutinating unit ($1$ HAU) is defined as the smallest amount of virus causing complete hemagglutination. The HAI assay uses an input of $4$ HAU per well.\n- **Serum Dilutions**: Two-fold serial dilutions ranging from $1{:}10$ to $1{:}1280$.\n- **RBC Concentration**: $0.5\\%$ (v/v) RBCs are added after serum-virus incubation.\n- **Readout Criteria**:\n    - **Complete Inhibition**: A compact RBC button with no lattice formation. This indicates sufficient antibodies neutralized the virus.\n    - **No Inhibition**: A uniform lattice of RBCs. This indicates insufficient antibodies to prevent virus-mediated agglutination.\n    - **Partial Inhibition**: An incomplete lattice or teardrop shape. This is explicitly defined as not meeting the criterion for complete inhibition.\n- **Experimental Observations**:\n    - Complete inhibition was observed at serum dilutions of $1{:}80$ and $1{:}160$.\n    - Partial inhibition was observed at a serum dilution of $1{:}320$.\n    - No inhibition was observed at serum dilutions of $1{:}640$ and higher.\n- **Titer Definition**: The HAI titer is defined as \"the reciprocal of the highest serum dilution that meets the complete inhibition criterion.\"\n- **Required Output**: A single unitless integer.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is evaluated based on the criteria of being scientifically grounded, well-posed, and objective.\n\n- **Scientific Grounding**: The problem describes a standard immunological assay (HAI) used widely in virology, particularly for influenza surveillance. The principles of viral hemagglutination and its inhibition by specific antibodies are fundamental concepts in immunology and virology. The definitions of HAU, the use of $4$ HAU, serial dilutions, and the interpretation of RBC buttons versus lattices are all standard laboratory practice. The problem is scientifically sound.\n- **Well-Posedness**: The problem provides all necessary information: the experimental results and a clear, unambiguous definition of the endpoint (HAI titer). The question is structured to have a unique and meaningful solution derivable directly from the supplied data and definitions.\n- **Objectivity**: The problem is stated using precise, objective, and technical language. It is free of ambiguity, subjective claims, or opinion.\n\n**Step 3: Verdict and Action**\nThe problem is deemed **valid**. It is a well-posed, scientifically grounded problem that requires the direct application of a defined technical term to a set of experimental data. The solution process may proceed.\n\n### Solution\n\nThe objective is to determine the HAI titer based on the provided experimental data and the specific definition of the titer.\n\nThe principle of the HAI assay is that antibodies in a patient's serum can neutralize the agglutinating property of a virus. The concentration of these antibodies is determined by serially diluting the serum and finding the highest dilution that still completely inhibits hemagglutination.\n\nThe problem provides the following results for the serial dilutions:\n1.  Serum dilution $1{:}80$: Complete inhibition.\n2.  Serum dilution $1{:}160$: Complete inhibition.\n3.  Serum dilution $1{:}320$: Partial inhibition.\n4.  Serum dilution $1{:}640$: No inhibition.\n\nThe problem explicitly states the rule for determining the endpoint: the HAI titer is the reciprocal of the **highest serum dilution that meets the complete inhibition criterion**.\n\nWe must identify all dilutions that showed \"complete inhibition\". According to the data, these are the dilutions $1{:}80$ and $1{:}160$.\n\nNext, we must identify the \"highest\" of these dilutions. A higher dilution corresponds to a more dilute sample, which is represented by a larger number in the denominator of the dilution ratio. Comparing the two dilutions that showed complete inhibition, $1{:}80$ and $1{:}160$, the highest dilution is $1{:}160$.\n\nThe dilution $1{:}320$ showed \"partial inhibition\", which, by the problem's definition, \"does not meet the criterion for complete inhibition\". Therefore, this dilution is not considered for determining the endpoint. The dilutions $1{:}640$ and higher showed no inhibition and are also not considered.\n\nThe endpoint of the titration is therefore the dilution $1{:}160$.\n\nFinally, the HAI titer is calculated as the reciprocal of this dilution. The reciprocal of the fraction $\\frac{1}{160}$ is given by:\n$$ \\text{Titer} = \\frac{1}{\\left(\\frac{1}{160}\\right)} = 160 $$\nThe resulting HAI titer is $160$. The problem asks for this value as a single unitless integer.", "answer": "$$\\boxed{160}$$", "id": "5088316"}, {"introduction": "Agglutination assays sometimes produce counter-intuitive results, such as the 'prozone effect,' where very high concentrations of antibody fail to produce agglutination. This phenomenon is not an error but a direct consequence of the molecular interactions at play. This exercise will guide you through a first-principles derivation to understand prozone in terms of antibody-epitope binding kinetics, demonstrating how to quantitatively predict the dilution needed to restore visible lattice formation. [@problem_id:5088317]", "problem": "A red blood cell (RBC) hemagglutination assay performed with patient serum shows a prozone effect at neat (undiluted) and at a $1{:}2$ dilution, but visible agglutination at $1{:}8$. The specific immunoglobulin G (IgG) that mediates agglutination is present in the neat serum at $200\\,\\mu\\mathrm{g/mL}$. The IgG molecular weight is $150{,}000\\,\\mathrm{g/mol}$, and the equilibrium dissociation constant ($K_d$) for IgG binding to the dominant RBC epitope under the assay conditions is $1.7\\times 10^{-7}\\,\\mathrm{M}$. Assume the total concentration of RBC epitopes is negligible relative to antibody across the dilutions considered, so that the free antibody concentration is approximately the diluted total antibody concentration. \n\nStarting from the law of mass action and the definition of $K_d$, derive the fractional occupancy of RBC epitopes by antibody as a function of free antibody concentration. Using first-principles reasoning about bivalent cross-linking, articulate a physically motivated occupancy criterion that alleviates the prozone and enables lattice formation. Then, determine the minimal whole-number fold dilution $d_{\\min}$ of serum required to satisfy this criterion under the stated conditions.\n\nExpress your final answer as the smallest whole-number fold dilution (dimensionless).", "solution": "## PROBLEM VALIDATION\n\n### Step 1: Extract Givens\n- Assay type: Red blood cell (RBC) hemagglutination assay.\n- Observation 1: Prozone effect at neat (undiluted) and $1{:}2$ dilution of patient serum.\n- Observation 2: Visible agglutination at $1{:}8$ dilution.\n- Neat immunoglobulin G (IgG) concentration in serum: $C_{\\text{neat}} = 200\\,\\mu\\mathrm{g/mL}$.\n- IgG molecular weight: $M_w = 150{,}000\\,\\mathrm{g/mol}$.\n- Equilibrium dissociation constant for IgG-epitope binding: $K_d = 1.7 \\times 10^{-7}\\,\\mathrm{M}$.\n- Assumption: Total concentration of RBC epitopes is negligible relative to antibody concentration, thus the free antibody concentration, $[Ab]_{\\text{free}}$, is approximately equal to the diluted total antibody concentration.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the validation criteria:\n- **Scientifically Grounded**: The problem is based on fundamental principles of immunochemistry and physical chemistry, specifically the law of mass action governing receptor-ligand binding, the bivalent nature of IgG antibodies, and the prozone (or high-dose hook) effect observed in immunoassays. These are well-established concepts in molecular and immunodiagnostics.\n- **Well-Posed**: The problem provides all necessary quantitative data ($C_{\\text{neat}}$, $M_w$, $K_d$) and a key simplifying assumption (free antibody concentration equals total diluted concentration) to allow for a unique, stable, and meaningful solution. The question is specific and answerable.\n- **Objective**: The problem is stated using precise, unbiased scientific language. The observations provided ($1{:}8$ agglutination) act as a consistency check rather than a subjective constraint.\n\nThe problem does not exhibit any invalidating flaws. It is not scientifically unsound, non-formalizable, incomplete, unrealistic, or ill-posed. The scenario described is a classic textbook example of the prozone effect in agglutination assays.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A full solution will be provided.\n\n## SOLUTION\n\nThe problem requires a three-part solution: first, the derivation of the fractional occupancy of RBC epitopes; second, the articulation of a physical criterion for agglutination; and third, the calculation of the minimal dilution factor to meet this criterion.\n\n### Part 1: Derivation of Fractional Occupancy\n\nLet $[E]$ be the concentration of free epitopes on the RBC surface, $[Ab]$ be the concentration of free antibody binding sites, and $[AbE]$ be the concentration of antibody-epitope complexes. The binding reaction is reversible:\n$$\nE + Ab \\rightleftharpoons AbE\n$$\nThe equilibrium dissociation constant, $K_d$, is defined by the law of mass action at equilibrium:\n$$\nK_d = \\frac{[E][Ab]}{[AbE]}\n$$\nThe total concentration of epitopes, $[E]_T$, is the sum of free and bound epitopes:\n$$\n[E]_T = [E] + [AbE]\n$$\nThe fractional occupancy, $\\theta$, is the fraction of total epitopes that are bound by antibody:\n$$\n\\theta = \\frac{[AbE]}{[E]_T}\n$$\nTo express $\\theta$ as a function of $[Ab]$ and $K_d$, we first rearrange the expression for $[E]_T$ to solve for $[E]$:\n$$\n[E] = [E]_T - [AbE]\n$$\nSubstitute this into the equation for $K_d$:\n$$\nK_d = \\frac{([E]_T - [AbE])[Ab]}{[AbE]}\n$$\nNow, we solve for the ratio $[AbE]/[E]_T$.\n$$\nK_d [AbE] = ([E]_T - [AbE])[Ab] = [E]_T [Ab] - [AbE][Ab]\n$$\n$$\nK_d [AbE] + [AbE][Ab] = [E]_T [Ab]\n$$\n$$\n[AbE](K_d + [Ab]) = [E]_T [Ab]\n$$\nDividing by $[E]_T$ and by $(K_d + [Ab])$, we obtain the expression for fractional occupancy:\n$$\n\\theta = \\frac{[AbE]}{[E]_T} = \\frac{[Ab]}{K_d + [Ab]}\n$$\nThis is the Langmuir adsorption isotherm, which describes the fractional occupancy of binding sites.\n\n### Part 2: Articulation of Agglutination Criterion\n\nAgglutination, or the formation of a macroscopic lattice of cross-linked RBCs, requires that bivalent IgG antibodies bridge separate cells. The prozone effect, observed at high antibody concentrations, occurs because the high density of antibodies leads to the saturation of epitopes on individual cells. When the fractional occupancy $\\theta$ approaches $1$, nearly every available epitope is bound. This monovalent saturation prevents a single antibody molecule from forming a bridge between two cells, thereby inhibiting lattice formation.\n\nTo alleviate the prozone effect and enable agglutination, the system must transition from this saturated state to one where cross-linking is favorable. Optimal cross-linking occurs when there is a balance between occupied and free epitopes on the cell surfaces. This allows a bivalent antibody to bind to an occupied site on one cell (or, more accurately, for one arm to bind to one cell and the other arm to find a free epitope on another cell). The probability of forming a cross-link is related to the product of the number of free sites and occupied sites, which is maximized when half the sites are free and half are occupied. This corresponds to a fractional occupancy of $\\theta = 0.5$.\n\nFrom the derived occupancy equation, setting $\\theta = 0.5$ yields:\n$$\n0.5 = \\frac{[Ab]}{K_d + [Ab]}\n$$\n$$\n0.5(K_d + [Ab]) = [Ab]\n$$\n$$\n0.5 K_d + 0.5 [Ab] = [Ab]\n$$\n$$\n0.5 K_d = 0.5 [Ab] \\implies [Ab] = K_d\n$$\nTherefore, a physically motivated criterion to move out of the prozone and enable lattice formation is to dilute the serum until the free antibody concentration becomes less than or equal to the dissociation constant, $K_d$.\n$$\n[Ab] \\le K_d\n$$\nThis condition ensures the system is no longer in epitope saturation ($\\theta \\approx 1$) and is at or near the optimal state for cross-linking ($\\theta \\le 0.5$).\n\n### Part 3: Calculation of Minimal Dilution\n\nFirst, we must calculate the molar concentration of IgG in the neat (undiluted) serum, $[Ab]_{\\text{neat}}$. Note that since IgG is bivalent, the concentration of binding sites is twice the concentration of IgG molecules. However, the equilibrium constant $K_d$ is typically defined with respect to the concentration of ligand molecules. The problem defines $K_d$ for \"IgG binding\", thus we will proceed using molar concentration of the IgG protein itself. The problem also simplifies this by having us use the diluted total antibody concentration as the free antibody concentration.\n\nThe given concentration is $C_{\\text{neat}} = 200\\,\\mu\\mathrm{g/mL}$. We convert this to units of $\\mathrm{g/L}$:\n$$\nC_{\\text{neat}} = 200\\,\\frac{\\mu\\mathrm{g}}{\\mathrm{mL}} = 200 \\times 10^{-6}\\,\\frac{\\mathrm{g}}{10^{-3}\\,\\mathrm{L}} = 0.2\\,\\frac{\\mathrm{g}}{\\mathrm{L}}\n$$\nThe molar concentration is the mass concentration divided by the molecular weight, $M_w = 150{,}000\\,\\mathrm{g/mol}$:\n$$\n[Ab]_{\\text{neat}} = \\frac{C_{\\text{neat}}}{M_w} = \\frac{0.2\\,\\mathrm{g/L}}{150{,}000\\,\\mathrm{g/mol}} = \\frac{2 \\times 10^{-1}}{1.5 \\times 10^5}\\,\\mathrm{mol/L} = \\frac{4}{3} \\times 10^{-6}\\,\\mathrm{M}\n$$\nLet $d$ be the fold dilution. The diluted antibody concentration, $[Ab]_d$, is:\n$$\n[Ab]_d = \\frac{[Ab]_{\\text{neat}}}{d}\n$$\nThe problem states to assume the free antibody concentration $[Ab]$ is approximately equal to the diluted total antibody concentration, so $[Ab] \\approx [Ab]_d$. Applying the criterion derived in Part 2:\n$$\n[Ab]_d \\le K_d\n$$\n$$\n\\frac{[Ab]_{\\text{neat}}}{d} \\le K_d\n$$\nTo find the minimal dilution, we solve for $d$:\n$$\nd \\ge \\frac{[Ab]_{\\text{neat}}}{K_d}\n$$\nThe minimal dilution, $d_{\\min}$, corresponds to the lower bound of this inequality. We substitute the known values for $[Ab]_{\\text{neat}}$ and $K_d = 1.7 \\times 10^{-7}\\,\\mathrm{M}$:\n$$\nd_{\\min} \\ge \\frac{\\frac{4}{3} \\times 10^{-6}\\,\\mathrm{M}}{1.7 \\times 10^{-7}\\,\\mathrm{M}}\n$$\n$$\nd_{\\min} \\ge \\frac{4 \\times 10^{-6}}{3 \\times 1.7 \\times 10^{-7}} = \\frac{40}{3 \\times 1.7} = \\frac{40}{5.1}\n$$\n$$\nd_{\\min} \\ge 7.8431...\n$$\nThe problem asks for the minimal **whole-number** fold dilution. The smallest integer value of $d$ that satisfies $d \\ge 7.8431...$ is $8$. Thus, the minimal whole-number fold dilution required is $8$. This result is consistent with the experimental observation that agglutination is visible at a $1{:}8$ dilution.", "answer": "$$\n\\boxed{8}\n$$", "id": "5088317"}, {"introduction": "A single assay result provides a point estimate, but robust scientific conclusions rely on understanding experimental variability through replication. Because titers from serial dilutions follow a multiplicative scale, they are best analyzed using logarithmic statistics. This hands-on problem will teach you the standard method for handling replicate titer data: calculating the Geometric Mean Titer (GMT) and its confidence interval, essential skills for accurately reporting and comparing immunological data. [@problem_id:5088335]", "problem": "In a hemagglutination assay, the endpoint titer is defined as the reciprocal of the highest dilution that produces the specified agglutination endpoint. In serial twofold dilutions, endpoints often appear as $1\\!:\\!d$ where $d$ is an integer multiple of $2$. For a specimen assayed in triplicate, the three endpoint titers are $1\\!:\\!80$, $1\\!:\\!160$, and $1\\!:\\!160$. Interpret these endpoints as the positive reciprocal titers $80$, $160$, and $160$.\n\nAdvanced immunodiagnostic practice treats titers as multiplicative quantities subject to log-normal variability across replicates. Under the assumption that the natural logarithm of titers is approximately normally distributed, the Geometric Mean Titer (GMT) is defined as the exponential of the arithmetic mean of the natural logarithms, and a two-sided confidence interval at confidence level $0.95$ for the GMT can be constructed by:\n1. Computing the confidence interval for the mean on the natural logarithm scale using Studentâ€™s $t$ distribution with $n-1$ degrees of freedom, and\n2. Back-transforming the interval endpoints by the exponential function to the titer scale.\n\nUsing only these foundations and the three titers $80$, $160$, and $160$, derive the GMT and the two-sided $0.95$ confidence interval for the GMT. Express the final numeric answers as pure numbers (dimensionless) and round each to three significant figures. Report the results in the order: GMT, lower confidence limit, upper confidence limit.", "solution": "The problem is well-posed and scientifically sound, providing a complete set of data and a standard procedure for statistical analysis of titer data in immunodiagnostics. We may proceed with the solution.\n\nThe given triplicate endpoint titers are interpreted as the positive reciprocal titers $T_1 = 80$, $T_2 = 160$, and $T_3 = 160$. The number of replicates is $n=3$. The analysis is performed under the assumption that the natural logarithm of the titers is normally distributed.\n\nFirst, we transform the titer data to the logarithmic scale using the natural logarithm, $y_i = \\ln(T_i)$.\nThe log-transformed data points are:\n$y_1 = \\ln(80)$\n$y_2 = \\ln(160)$\n$y_3 = \\ln(160)$\n\nThe Geometric Mean Titer (GMT) is defined as the exponential of the arithmetic mean of the log-transformed titers. The arithmetic mean of the $y_i$ values, denoted as $\\bar{y}$, is:\n$$ \\bar{y} = \\frac{1}{n} \\sum_{i=1}^{n} y_i = \\frac{\\ln(80) + \\ln(160) + \\ln(160)}{3} $$\nUsing the logarithmic property $\\ln(a) + \\ln(b) = \\ln(ab)$, we can simplify the numerator:\n$$ \\bar{y} = \\frac{\\ln(80 \\times 160 \\times 160)}{3} = \\frac{\\ln(2048000)}{3} $$\nThe GMT is the back-transformation of $\\bar{y}$:\n$$ \\text{GMT} = \\exp(\\bar{y}) = \\exp\\left( \\frac{\\ln(2048000)}{3} \\right) = (2048000)^{1/3} $$\nTo express this in a more elegant form, we can use prime factorization.\n$80 = 5 \\times 16 = 5 \\times 2^4$\n$160 = 10 \\times 16 = 5 \\times 2 \\times 2^4 = 5 \\times 2^5$\n$$ \\text{GMT} = ((5 \\times 2^4) \\times (5 \\times 2^5) \\times (5 \\times 2^5))^{1/3} = (5^3 \\times 2^{14})^{1/3} = 5 \\times 2^{14/3} = 80 \\sqrt[3]{4} $$\nNumerically, this value is:\n$$ \\text{GMT} \\approx 126.992 $$\nRounding to three significant figures, we get $\\text{GMT} = 127$.\n\nNext, we construct the $0.95$ confidence interval for the GMT. This requires calculating the confidence interval for the mean on the log scale and then back-transforming its endpoints.\nThe sample variance of the log-transformed data, $s_y^2$, is given by:\n$$ s_y^2 = \\frac{1}{n-1} \\sum_{i=1}^{n} (y_i - \\bar{y})^2 $$\nWith $n=3$, the degrees of freedom are $df = n-1 = 2$.\nThe deviations from the mean are:\n$y_1 - \\bar{y} = \\ln(80) - \\frac{\\ln(80)+2\\ln(160)}{3} = \\frac{2}{3}(\\ln(80) - \\ln(160)) = \\frac{2}{3}\\ln(\\frac{80}{160}) = -\\frac{2}{3}\\ln(2)$\n$y_2 - \\bar{y} = \\ln(160) - \\frac{\\ln(80)+2\\ln(160)}{3} = \\frac{1}{3}(\\ln(160) - \\ln(80)) = \\frac{1}{3}\\ln(\\frac{160}{80}) = \\frac{1}{3}\\ln(2)$\n$y_3 - \\bar{y} = y_2 - \\bar{y} = \\frac{1}{3}\\ln(2)$\nThe sum of squared deviations is:\n$$ \\sum_{i=1}^{n} (y_i - \\bar{y})^2 = \\left(-\\frac{2}{3}\\ln(2)\\right)^2 + \\left(\\frac{1}{3}\\ln(2)\\right)^2 + \\left(\\frac{1}{3}\\ln(2)\\right)^2 = \\frac{4}{9}(\\ln(2))^2 + \\frac{1}{9}(\\ln(2))^2 + \\frac{1}{9}(\\ln(2))^2 = \\frac{6}{9}(\\ln(2))^2 = \\frac{2}{3}(\\ln(2))^2 $$\nThe sample variance is:\n$$ s_y^2 = \\frac{1}{2} \\left( \\frac{2}{3}(\\ln(2))^2 \\right) = \\frac{1}{3}(\\ln(2))^2 $$\nThe sample standard deviation is therefore:\n$$ s_y = \\sqrt{\\frac{1}{3}(\\ln(2))^2} = \\frac{\\ln(2)}{\\sqrt{3}} $$\nThe confidence interval for the mean of the log-transformed data, $\\mu_y$, is given by:\n$$ \\text{CI}_{\\mu_y} = \\bar{y} \\pm t_{\\alpha/2, n-1} \\frac{s_y}{\\sqrt{n}} $$\nFor a $0.95$ confidence level, $\\alpha = 0.05$, so $\\alpha/2 = 0.025$. With $df = 2$, the critical value from the Student's $t$-distribution is $t_{0.025, 2} = 4.303$.\nThe standard error of the mean for the log-data is:\n$$ \\text{SEM}_y = \\frac{s_y}{\\sqrt{n}} = \\frac{\\ln(2)/\\sqrt{3}}{\\sqrt{3}} = \\frac{\\ln(2)}{3} $$\nThe margin of error (ME) for the log-mean is:\n$$ \\text{ME} = t_{0.025,2} \\times \\text{SEM}_y = 4.303 \\times \\frac{\\ln(2)}{3} \\approx 0.99419 $$\nThe confidence interval on the log scale is:\n$$ \\text{CI}_{\\mu_y} = \\bar{y} \\pm \\text{ME} \\approx \\ln(126.992) \\pm 0.99419 \\approx 4.84412 \\pm 0.99419 $$\nThis gives the interval $[3.84993, 5.83831]$.\nTo find the confidence interval for the GMT, we back-transform the endpoints of this interval using the exponential function:\n$$ \\text{CI}_{\\text{GMT}} = [\\exp(3.84993), \\exp(5.83831)] $$\nThe lower confidence limit (LCL) is:\n$$ \\text{LCL} = \\exp(\\bar{y} - \\text{ME}) = \\frac{\\exp(\\bar{y})}{\\exp(\\text{ME})} = \\frac{\\text{GMT}}{\\exp(\\text{ME})} \\approx \\frac{126.992}{\\exp(0.99419)} \\approx 46.991 $$\nThe upper confidence limit (UCL) is:\n$$ \\text{UCL} = \\exp(\\bar{y} + \\text{ME}) = \\exp(\\bar{y}) \\times \\exp(\\text{ME}) = \\text{GMT} \\times \\exp(\\text{ME}) \\approx 126.992 \\times \\exp(0.99419) \\approx 343.193 $$\nRounding the results to three significant figures as required:\nGMT: $127$\nLCL: $47.0$\nUCL: $343$\nThe results are reported in the order: GMT, lower confidence limit, upper confidence limit.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n127  47.0  343\n\\end{pmatrix}\n}\n$$", "id": "5088335"}]}